Hans Jörg Reinhardt
Voorzitter bij NOVARTIS AG
Vermogen: 69 M $ op 31-12-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Vasant Narasimhan | M | 49 |
Novartis Foundation
Novartis Pharma BV
![]() Novartis Pharma BV Part of Novartis AG, Novartis Pharma BV is a Dutch healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Amsterdam, the Netherlands. Novartis is one of the largest pharmaceutical companies in the world. The company explores and develop innovative treatment methods to reach as many people as possible. The company was founded in 1996. The CEO is Vasant Narasimhan.
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 20 jaar |
Bill Winters | M | 63 |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 12 jaar |
Nancy Andrews | M | 65 |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 10 jaar |
Harry Werner Kirsch | M | 60 |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | 22 jaar |
Jacques de Vaucleroy | M | 64 | 8 jaar | |
Pravina Ladva | F | - | 8 jaar | |
Andreas von Planta | M | 69 |
Novartis Foundation
| - |
Shannon Klinger | M | 54 |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | 11 jaar |
Shreeram Aradhye | M | 63 |
Novartis Pharma AG
![]() Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | 3 jaar |
William Brody | M | 81 |
Novartis, Inc.
![]() Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | 16 jaar |
Albert Bourla | M | 63 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Karen Gavan | F | 64 | 7 jaar | |
Otmar D. Wiestler | M | 68 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | 21 jaar |
Nikolaus Blum | M | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Kaspar Müller | M | 52 | 15 jaar | |
Larry Zimpleman | M | 73 | 7 jaar | |
Andreas Berger | M | 58 | 6 jaar | |
Bik Yun Lau | F | 52 | 2 jaar | |
Thomas N. Kendris | M | - |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 9 jaar |
Steffen Lang | M | 58 | 8 jaar | |
Deanna Ong | F | - | 5 jaar | |
Joachim Oechslin | M | 55 | 5 jaar | |
Samir Shah | M | 64 | 21 jaar | |
Frans van Houten | M | 64 | 8 jaar | |
Paul Tucker | M | 67 | 9 jaar | |
Holger Hanselka | M | 64 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Géraldine Matchett | F | 53 | - | |
Patrice Bula | M | 69 | 6 jaar | |
Jay Stuart Ralph | M | 65 | 8 jaar | |
Liz Doherty | F | 68 | 9 jaar | |
Velina Peneva | F | - | 8 jaar | |
Simon Moroney | M | 66 | 5 jaar | |
Lutz Hegemann | M | 59 |
Novartis Foundation
| - |
John Young | M | 61 | 2 jaar | |
Bridgette Heller | F | 63 | 5 jaar | |
Ana de Pro Gonzalo | F | 58 | 3 jaar | |
Daniel Hochstrasser | M | 65 | 3 jaar | |
Ton Büchner | M | 60 | 9 jaar | |
Brigitte Meier | F | - | 23 jaar | |
John Dacey | M | 65 | 13 jaar | |
Philip Ryan | M | 69 | 10 jaar | |
Günther Wess | M | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Charles Sawyers | M | 66 | 12 jaar | |
Peter M. Herzig | M | 70 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Gianfranco Lot | M | 54 | - | |
Jim Pearse | M | - | 4 jaar | |
Kees Roks | M | 62 | 3 jaar | |
Samrat Dua | M | 53 | 4 jaar | |
Veronica Scotti | F | - | 7 jaar | |
Pia Tischhauser | F | - | 2 jaar | |
Scott Brown | M | - |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | - |
Ali Shahkarami | M | - | 2 jaar | |
Antonio Esteve Cruella | M | 67 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Dieter Weinand | M | 64 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Russell Higginbotham | M | - | 7 jaar | |
Ulf Arne Wiinberg | M | 67 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Ian Read | M | 72 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Stefan Oschmann | M | 67 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Urs Baertschi | M | - | 6 jaar | |
Olivier Brandicourt | M | 68 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Cathy Desquesses | F | - | 4 jaar | |
Tapan Durgadas Ray | M | 67 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jorge Gallardo Ballart | M | 83 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 21 jaar |
Franziska Broer | F | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | 18 jaar |
Wolfgang Plischke | M | 73 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | 10 jaar |
Paola Ricci | F | 67 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Ugo di Francesco | M | 64 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Horst Stöcker | M | - |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Charlotte Pamer-Wieser | M | - | 14 jaar | |
Roger Connor | M | - |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Heike Hanagarth | M | 65 |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
![]() Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | - |
Paul Murray | M | - | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Relaties uit het verleden
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Joseph Jimenez | M | 65 | 11 jaar | |
Giancarlo Mocchi | M | 85 | 3 jaar | |
Ulrich Lehner | M | 78 | 13 jaar | |
Thomas Ebeling | M | 65 | 12 jaar | |
Pierre Landolt | M | 78 | 22 jaar | |
Rolf M. Zinkernagel | M | 81 | 15 jaar | |
Wendelin Wiedeking | M | 73 | 11 jaar | |
Sergio Ermotti | M | 64 | 3 jaar | |
Thomas Wellauer | M | 70 | 9 jaar | |
Ronen Tamir | M | 58 | - | |
Carlos Eduardo Represas de Almeida | M | 79 | 7 jaar | |
Renato Fassbind | M | 70 | 11 jaar | |
Dimitri Azar | M | 66 | 7 jaar | |
David Cole | M | 63 | 10 jaar | |
Margot A. Scheltema | M | 70 | 8 jaar | |
Julia Higgins | M | 83 | 6 jaar | |
Antonio Trius Oliva | M | 69 | - | |
Walter Kielholz | M | 73 | 32 jaar | |
Werner J. Bauer | M | 74 | 9 jaar | |
Mary Francis | F | 76 | 5 jaar | |
Mun Tak Yang | F | 71 | - | |
Daniel Camus | M | 70 | 12 jaar | |
Metin Colpan | M | 70 | 8 jaar | |
Kuo Fung Ch'ien | M | 74 | 14 jaar | |
Richard Sykes | M | 80 | 10 jaar | |
Gerhard Mayr | M | 79 | 7 jaar | |
Trevor Manuel | M | 69 | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zwitserland | 87 | 87.88% |
Duitsland | 11 | 11.11% |
Verenigde Staten | 5 | 5.05% |
Nederland | 1 | 1.01% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Provenance des relations
- Beurs
- Insiders
- Hans Jörg Reinhardt
- Persoonlijk netwerk